PETACH-TIKVA, Israel--Compugen here has begun shipping BioXL, its newest high-end sequence analysis computer system designed for target discovery. The scalable system includes proprietary components on both the hardware and the software side. "With BioXL's superior functionality, algorithmic range, and computational power that scales to more than 50-gig matrix cell updates per second, our clients can now enjoy the ultimate solution for sequence data mining," claimed Meir Yedidia, Compugen's marketing manager of sequence analysis products.
Compugen develops proprietary bioinformatics technologies and markets them to pharmaceutical and genomics companies for use in analyzing genomic and protein sequence data and discovering of new drug leads. The company has satellite offices in Woburn, Mass., and Japan.